Brief: AIM Vaccine's Unit Obtains Production License For Serum-Free Rabies Vaccine
12/03/2025 01:37
March 12 (Reuters) - AIM Vaccine Co Ltd 6660.HK: UNIT OBTAINS PRODUCTION LICENSE FOR SERUM-FREE RABIES VACCINE OBTAINS PRODUCTION LICENSE FOR SERUM-FREE RABIES VACCINE Further company coverage: 6660.HK ((Reuters.Briefs@thomsonreuters.com))
Recent news on AIM Vaccine
See all newsBrief: AIM Vaccine Co Submits Application For Human Diploid Cell Rabies Vaccine In China
Brief: AIM Vaccine Says Tibet Bohai To Subscribe 37.4 Million Shares At RMB1.07 Each
Brief: AIM Vaccine Approves Issuance Of Up To 40 Million Domestic Shares
Brief: Aim Vaccine Says Serum-Free Rabies Vaccine Passes Inspection
Brief: AIM Vaccine Updates On 20-Valent Pneumococcal Polysaccharide Conjugate Vaccine